NEW YORK, Oct 12— Moderna Inc today said the US Food and Drug Administration should authorize booster doses of its Covid-19 vaccine in fully vaccinated older adults and other high-risk individuals.

The company said its data supports the public health benefit of a booster dose of its vaccine to restore immune response, while reducing the number of "breakthrough” infections in fully-vaccinated adults.

Moderna’s comments were released in briefing documents ahead of a Thursday meeting of the FDA’s outside expert advisers to discuss the booster dose. — Reuters